JBIO vs AMGN: Which Stock is Better?
Side-by-side comparison of Jade Biosciences Inc and Amgen Inc in 2026
JBIO
Jade Biosciences Inc
$22.85
AMGN
Amgen Inc
$355.30
Key Metrics Comparison
| Metric | JBIO | AMGN | Winner |
|---|---|---|---|
| Market Cap | $1.13B | $191.53B | AMGN |
| P/E Ratio | N/A | 24.93 | AMGN |
| EPS (TTM) | $N/A | $14.25 | AMGN |
| Revenue Growth | 0.0% | 0.1% | AMGN |
| Gross Margin | 0.0% | 70.8% | AMGN |
Analyze JBIO
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is JBIO or AMGN a better investment?
Comparing JBIO and AMGN: Jade Biosciences Inc has a market cap of $1.13B while Amgen Inc has $191.53B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between JBIO and AMGN?
JBIO (Jade Biosciences Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: JBIO or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: JBIO or AMGN?
AMGN has higher revenue growth at 0.1% vs 0.0% for JBIO.
Which company is more profitable: JBIO or AMGN?
Amgen Inc (AMGN) has higher gross margins at 70.8% compared to 0.0% for JBIO.
Which is the larger company: JBIO or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $191.53B compared to $1.13B for JBIO.
Should I buy JBIO or AMGN in 2026?
Both JBIO and AMGN have investment merit. JBIO trades at $22.85 while AMGN trades at $355.30. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between JBIO and AMGN stock?
Key differences: Market Cap ($1.13B vs $191.53B), P/E Ratio (N/A vs 24.9x), Revenue Growth (0.0% vs 0.1%), Gross Margin (0.0% vs 70.8%).